Table 3 Characterization of genomic regions (2nd to 3rd columns in GRCh38) by each capture kit

From: Human whole-exome genotype data for Alzheimer’s disease

Capture kit info

Number of original capture regions (various genome builds)

Number of lifted-over capture regions (GRCh38)

Number of bp

% of capture regions that are Ensembl v94 exons

% of Ensembl v94 exons (with flanking 7bp) that are captured

Agilent WES v3 capture region

206,773

206,445

52,941,356

92.54

95.13

Agilent WES v4 capture region

185,638

185,600

53,791,945

92.11

94.14

Agilent WES v5 capture region

230,418

230,348

53,309,273

89.97

96.27

Agilent WES v6 capture region

232,406

231,980

61,549,327

87.78

95.88

IDT xGen Exome Whole-Exome Research Panel v1.0 w-Custom Spike-In Baits

203,403

203,310

39,968,963

94.05

95.20

Illumina rapid capture exome (ICE) kit

217,234

216,807

40,653,755

91.17

98.03

Nimblegen VCRome sequencing w-Custom Spike-In Baits

244,944

244,828

41,708,836

96.26

93.63

Roche Nimblegen VCRome V2.1

197,542

195,167

37,951,907

96.05

94.39

Roche SeqCap EZ Exome Probes v2.0 Target Enrichment Probes

259,651

244,490

47,294,869

94.68

92.34

Roche SeqCap EZ Exome Probes v3.0 Target Enrichment Probes

368,146

367,730

69,167,416

83.01

97.14

  1. bp basepairs. First column shows the original number of capture regions per capture kit in the original genome build. The second column shows the number of lifted-over capture regions per capture kit (in GRCh38), while the rest of the columns show the size of targeted genomic regions, the percentage of capture regions that are within Ensembl v94 exons, and the percentage of the Ensembl v94 exons (with flanking bps) that are captured by each of the kits.